Kenji Morimoto
-
- Diet, Metabolism, and Disease 38
- Biochemistry top 10%
-
- Lung Cancer Research Studies 16
- Cancer Immunotherapy and Biomarkers 13
- Organic Chemistry top 10%
- Carbohydrate Chemistry and Synthesis 6
-
- Lung Cancer Treatments and Mutations 25
- Lung Cancer Diagnosis and Treatment 7
-
- Pancreatic function and diabetes 11
-
- Neuroendocrine Tumor Research Advances 7
- Co-authors
- Ken IzumoriGoro TakataTom GranströmAkihide YoshiharaGoro TakadaGeorge W. J. FleetKeiko UechiKhim Leang
- Journals
- SHILAP Revista de lepidopterología (1 paper)Blood (1 paper)PLoS ONE (1 paper)
- Partner nations
- JapanUnited KingdomUnited States
In The Last Decade
Kenji Morimoto
113 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 110
- Endocrinology, Diabetes and Metabolism 673
- Biochemistry 54
- Oncology 200
- Organic Chemistry 206
- Molecular Biology 441
Countries citing papers authored by Kenji Morimoto
This map shows the geographic impact of Kenji Morimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Morimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Morimoto more than expected).
Fields of papers citing papers by Kenji Morimoto
This network shows the impact of papers produced by Kenji Morimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Morimoto. The network helps show where Kenji Morimoto may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kenji Morimoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2023 | 5 | |
| 3 | 2023 | 5 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 7 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 7 | |
| 9 | 2023 | 8 | |
| 10 | 2023 | 3 | |
| 11 | 2022 | 5 | |
| 12 | 2022 | 5 | |
| 13 | 2022 | 3 | |
| 14 | 2021 | 33 | |
| 15 | 2021 | 1 | |
| 16 | 2021 | 12 | |
| 17 | 2020 | 12 | |
| 18 | [Gasserian ganglion block for trigeminal neuralgia under dexmedetomidine sedation]. | 2014 | 1 |
| 19 | 1989 | 2 | |
| 20 | 1985 | 1 |
About Kenji Morimoto
Kenji Morimoto is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Pulmonary and Respiratory Medicine, having authored 117 papers that have together received 1.5k indexed citations. Recurring topics across this work include Diet, Metabolism, and Disease (38 papers), Lung Cancer Treatments and Mutations (25 papers), Lung Cancer Research Studies (16 papers), Cancer Immunotherapy and Biomarkers (13 papers), Pancreatic function and diabetes (11 papers), Neuroendocrine Tumor Research Advances (7 papers), Lung Cancer Diagnosis and Treatment (7 papers) and Carbohydrate Chemistry and Synthesis (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (673 citations), Biochemistry (54 citations) and Oncology (200 citations). Kenji Morimoto has collaborated with scholars based in Japan, United Kingdom and United States. Frequent co-authors include Ken Izumori, Goro Takata, Tom Granström, Akihide Yoshihara, Goro Takada, George W. J. Fleet, Keiko Uechi, Khim Leang, Sarah F. Jenkinson and Tadaaki Yamada. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.